pharma · Colon Carcinoma Metastatic in the Liver · Metastatic Melanoma · VCNX
Vaccinex
VACCINEX, INC.
Vaccinex is a pharma organization headquartered in Rochester, USA. It trades on NYSE under ticker VCNX. Primary therapeutic focus areas include Colon Carcinoma Metastatic in the Liver, Metastatic Melanoma, Metastatic Pan
1895 Mt Hope Ave, Rochester, New York 14620, US HQ
28 Employees
Public company Type
VCNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1895 Mt Hope Ave, Rochester, New York 14620, US
- Employees
- 28
- Programs
- 11
- Drugs
- 8
- Patents
- 41
VX15/2503
Phase 1 · mab · Squamous Cell Carcinoma of the Head and Neck
VX15/2503 for Squamous Cell Carcinoma of the Head and Neck is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Internal code IRB00103534
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- VACCINEX, INC.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Squamous Cell Carcinoma of the Head and Neck
- Status
- active
- Trials
- 1